LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Home・Stock List・Stryker Corp

Stryker Corp

Closed

SectorHealthcare

306.35 0.28

Buy Sell

Overview

Share price change

24h

Current

Min

303.12

Max

310.87

Key metrics
By Trading Economics
Income	-104M 745M
Sales	-1.2B 6B
P/E Sector Avg	32.668 51.415
EPS	1.93
Dividend yield	1.21
Profit margin	12.375
Employees	56,000
EBITDA	-478M 1.2B

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+29.65% upside

Dividends
By Dow Jones
Dividend yield Sector Avg	1.21% 2.34%
Next Earnings	30 Jul 2026
Next Dividend date	30 Jul 2026
Next Ex Dividend date	29 Jun 2026

Market Stats
By TradingEconomics
Market Cap	-18B 108B
Previous open	306.07
Previous close	306.35

News Sentiment

By Acuity

35%

65%

108 / 345 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

373.92 / 383.99 Support & Resistance

Stryker Corp Chart

Past performance is not a reliable indicator of future results.

Related News

30 Apr 2026, 20:41 UTC

Earnings

Stryker 1Q Sales, Profit Rise as it Dealt with Cyberattack

12 Mar 2026, 21:42 UTC

Major News Events

Stryker Says Cyberattack Disruption Is Continuing

11 Mar 2026, 19:18 UTC

Major Market Movers

Stryker Shares Down After Cyberattack Tied to Iran-Linked Group

29 Jan 2026, 22:05 UTC

Earnings

Stryker Logs Higher 4Q Profit On Sales Gains

30 Oct 2025, 20:36 UTC

Earnings

Stryker Lifts Fiscal Year Sales View After 3Q Revenue Rises

30 Apr 2026, 20:06 UTC

Earnings

Stryker 1Q Organic Net Sales Up 2.4%

30 Apr 2026, 20:06 UTC

Earnings

Stryker Backs FY26 Adj EPS $14.90-Adj EPS $15.10 >SYK

30 Apr 2026, 20:05 UTC

Earnings

Stryker Still Sees FY26 Organic Sales Grwoth 8% to 9.5%

30 Apr 2026, 20:05 UTC

Earnings

Stryker 1Q Adj EPS $2.60 >SYK

30 Apr 2026, 20:05 UTC

Earnings

Stryker 1Q EPS $1.93 >SYK

30 Apr 2026, 20:05 UTC

Earnings

Stryker 1Q Net $745M >SYK

30 Apr 2026, 20:05 UTC

Earnings

Stryker 1Q Sales $6.02B >SYK

30 Apr 2026, 20:05 UTC

Earnings

Stryker 1Q Net $745M >SYK

30 Apr 2026, 20:05 UTC

Earnings

Stryker 1Q Adj EPS $2.60 >SYK

30 Apr 2026, 20:05 UTC

Earnings

Stryker 1Q EPS $1.93 >SYK

30 Apr 2026, 20:05 UTC

Earnings

Stryker 1Q Sales $6B >SYK

9 Apr 2026, 20:55 UTC

Earnings

Stryker: Believes Incident Hasn't Had, and Isn't Reasonably Likely to Have, a Material Impact on 2026 Full-Year Guidance >SYK

9 Apr 2026, 20:55 UTC

Earnings

Stryker: Determined Incident Had Material Impact on Operations, With Resulting Impact on Financial Results for 1Q >SYK

9 Apr 2026, 20:55 UTC

Earnings

Stryker: Investigation of Cybersecurity Incident Remains Ongoing >SYK

16 Mar 2026, 00:00 UTC

Major News Events

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

30 Jan 2026, 17:03 UTC

Market Talk

Stryker's 4Q Results Signal 2026 Growth -- Market Talk

29 Jan 2026, 21:07 UTC

Earnings

Stryker Sees 2026 Organic Net Sales Growth 8%-9.5%

29 Jan 2026, 21:05 UTC

Earnings

Stryker 4Q Adj EPS $4.47 >SYK

5 Nov 2025, 19:38 UTC

Earnings

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 Nov 2025, 17:00 UTC

Earnings

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

30 Oct 2025, 20:21 UTC

Earnings

Stryker Lifts FY Sales View After 3Q Revenue Rises

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q Adj EPS $3.19 >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q EPS $2.22 >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q Sales $6.1B >SYK

30 Oct 2025, 20:05 UTC

Earnings

Stryker 3Q Net $859M >SYK

Peer Comparison

Price change

Stryker Corp Forecast

Price Target

By TipRanks

29.65% upside

12 Months Forecast

Average 391.67 USD 29.65%

High 465 USD

Low 315 USD

Based on 23 Wall Street analysts offering 12 month price targets forStryker Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

23 ratings

Buy

Hold

Sell

Based on 23 analysts giving stock ratings to Stryker Corp - Dist in the past 3 months.

Technical Score

By Trading Central

373.92 / 383.99Support & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

108 / 345 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.